A detailed history of Keebeck Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 16,854 shares of ABT stock, worth $1.99 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
16,854
Previous 17,336 2.78%
Holding current value
$1.99 Million
Previous $1.8 Million 6.66%
% of portfolio
0.29%
Previous 0.27%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $48,233 - $56,938
-482 Reduced 2.78%
16,854 $1.92 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $113,321 - $126,495
-1,125 Reduced 6.09%
17,336 $1.8 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $32,417 - $35,804
-296 Reduced 1.58%
18,461 $2.1 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $14,069 - $17,222
-156 Reduced 0.82%
18,757 $2.06 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $38,976 - $46,764
408 Added 2.2%
18,913 $1.83 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $246,306 - $274,436
2,444 Added 15.22%
18,505 $2.02 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $206,796 - $243,411
2,135 Added 15.33%
16,061 $1.63 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $23,955 - $28,103
252 Added 1.84%
13,926 $1.53 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $68,312 - $79,093
706 Added 5.44%
13,674 $1.32 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $1.86 Million - $2.25 Million
-18,256 Reduced 58.47%
12,968 $1.41 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $143,437 - $174,912
1,258 Added 4.2%
31,224 $3.7 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $77,289 - $94,636
669 Added 2.28%
29,966 $4.22 Million
Q3 2021

Nov 16, 2021

SELL
$116.66 - $129.06 $315,798 - $349,365
-2,707 Reduced 8.46%
29,297 $3.46 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $455,954 - $536,724
4,310 Added 15.56%
32,004 $3.71 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $445,808 - $525,230
-4,096 Reduced 12.88%
27,694 $3.32 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $189,315 - $206,299
-1,803 Reduced 5.37%
31,790 $3.48 Million
Q3 2020

Nov 02, 2020

BUY
$91.64 - $111.29 $162,752 - $197,651
1,776 Added 5.58%
33,593 $3.66 Million
Q2 2020

Aug 06, 2020

BUY
$76.57 - $98.0 $127,795 - $163,562
1,669 Added 5.54%
31,817 $2.91 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $215,409 - $314,987
3,429 Added 12.83%
30,148 $2.38 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $2.1 Million - $2.34 Million
26,719 New
26,719 $2.32 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Keebeck Wealth Management, LLC Portfolio

Follow Keebeck Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.